Translation and adaptation of the Rating of Medication Influences (ROMI): An instrument to assess compliance to treatment;Tradução e adaptação da Escala de Influências Medicamentosas (ROMI): Um instrumento para avaliar a aderência ao tratamento

Jornal Brasileiro de Psiquiatria

Volumn 49, Issue 10-12, 2000, Pages 405-412

  Rosa, Moacyr Alexandro ^a   Marcolin, Marco Antônio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antipsychotics; Compliance; Schizophrenia; Treatment

Indexed keywords

NEUROLEPTIC AGENT;

ADAPTATION; ADULT; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTROLLED STUDY; DATA ANALYSIS; DRUG ATTITUDE INVENTORY SCORE; FEMALE; HUMAN; LANGUAGE; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PSYCHIATRY; QUESTIONNAIRE; RATING OF MEDICATION INFLUENCES; RATING SCALE; REVIEW; SCHIZOPHRENIA; STANDARD;

EID: 0242433110     PISSN: 00472085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Awad A.G. Subjective response to neuroleptics in schizophrenia. Schizophr Bull 1993;19:609-18.
2. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacotherapy 1993;27(suppl):5-24.
3. Blackwell B. Treatment adherence. Brit J Psychiat 1976; 129:513-31.
4. Buchanan A. A two-years prospective study of treatment compliance in patients with schizophrenia. Psychol Med 1992;22:787-97.
5. Davis, MS. Predicting non-compliant behavior. Journal of Health and Social Behavior 1967;8:265-71.
6. Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Internal Med 1984;100:258-68.
7. Friedman M. Compliance with chronic disease regimens: diabetes. J Diabetic Compl 1988;2:140-4.
8. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983;13:117-83.
9. Kissling W. Compliance, quality assurance and standards for relapse prevention in schizophrenia. Acta Psychiatr Scand 1994;89(suppl 382):16-24.
10. Rosa, MA. Avaliação dos fatores de aderência ao tratamento medicamentoso em pacientes esquizofrênicos [dissertaç ão]. São Paulo (SP): Universidade de São Paulo; 1998.
11. Sacket DL. The magnitude of compliance and noncompliance. In: Sacket DL, Haynes RB, editors. Compliance with therapeutic regimens. Baltimore, MD: Johns Hopkins University Press:1976, p. 9-25.
12. Serban G, Thomas A. Attitudes and behaviors of acute and chronic schizophrenic patients regarding ambulatory treatment. Am J Psychiatry 1974;131:991-5.
13. Shope JT. Compliance in children and adults: a review of studies. In: Schmidt D, Leppik IE, editors. Compliance in epilepsy (Epilepsy Research Supplement 1). New York: Elsevier Science Publishers; 1988, p.23-47.
14. van Putten T, May PRA. Subjective response as a predictor of outcome in pharmacotherapy. Arch Gen Psychiatry 1978;35:477-80.
15. Weiden PJ, Rapkin B, Mott T, Zygmunt A, Goldman D, Horvitz-Lennon M, Frances, A. Rating of Medication Influences (ROMI) scale in schizophrenia. Schizophr Bull 1994;20:297-309.
16. Weiden PJ, Dixon L, Frances A, Appelbaum P, Haas G, Rapkin B. Neuroleptic noncompliance in schizophrenia. In: Tamminga CA & Schulz SC, editors. Advances in neuropsychiatry and psychopharmachology: Schizophrenia Research. Vol. 1. New York: Raven Press; 1991, p. 285-96.